Tag
$NUMI
- Numinus gets new biosecurity licence to expand psilocybin research
- Numinus submits novel psilocybe formulation for clinical trial
- Numinus develops in‑house tests to detect compounds in psychedelic mushrooms
- Numinus to test natural psilocybin safety in Phase 1 trial
- MagicMed aims to mainstream psychedelic therapy with world's largest 'Psybrary'
- Numinus licensed by Health Canada to extract and research psilocybin
- Canada could regulate psychedelic therapy within few years, bets company